Shukla Sanjay's Form 4 filing
aTYR PHARMA INC (ATYR) · filed Jan 10, 2022
- Accession no.
- 0001209191-22-002768
- Filed
- Jan 10, 2022
- Trade date
- Jan 7, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $33.8K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shukla SanjayCIK 0001671026 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $6.76 | +$33,800 | 25,798 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.